High levels of P2RX5 expression predicts a poor prognosis and promotes tumor progression in endometrial cancer

Read full text Summarise with VIRAT
Authors: Li-Yan Huang, Qun-Ying Su, Qin-Qin Long, Feng-Qin Tian, Xiao-Ying Zhu, Xi-Dai Long
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: This study aims to investigate the impact of P2RX5 on the clinical pathological characteristics and prognosis of endometrial carcinoma, and to explore its potential underlying mechanisms. METHODS: The clinical samples, including 150 specimens with endometrial carcinoma (Case group) and 100 endometrial samples without cancer (Control group), were collected for analyzing the amount of P2RX5 expression. Cell biology experiments were also used for exploring the effects of P2RX5 expression on biological behaviors of endometrial carcinoma. RESULTS: < 0.05). CONCLUSION: These findings suggest a critical role of P2RX5 in endometrial cancer progression and thereby establish the value of P2RX5 as a prognostic biomarker and provide a promising therapeutic target for endometrial cancer treatment.

Fields of Study & Subjects

Adenosine and Purinergic Signaling Endometrial and Cervical Cancer Treatments Breast Cancer Treatment Studies

Publication details

Journal / source
International Journal of Clinical and Experimental Pathology
Volume
19
Issue
3
Pages
146–159
Publication date
1 January 2026
Language
EN